We next empirically measured the HLA Class I and Class II (HLA-DR) immunopeptidomes of thirteen primary AML tumor samples (Table 1), with mass spectrometry using 1 X 108 cells per MHC preparation. The gene discussed is HLA-C; the disease is acute myeloid leukemia.